Sci-B-Vac

2 stories · following the connections

Business

VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXApr 19, 2018, 12:00 PM UTC

Business

VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXDec 19, 2017, 1:00 PM UTC